CS1 saturation of bone marrow CD38⁺ cells at day 56. Symbols indicate observed data from individual patients at each dose level. The vertical line indicates target level of serum elotuzumab concentration (70 μg/mL) based on preclinical studies. BM indicates bone marrow; and Emax, maximum effect.